(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 5B | +1% |
Gross Profit | 3B | +3% |
Cost Of Revenue | 2B | -2% |
Operating Income | 1.1B | +4% |
Operating Expenses | 1.9B | - |
Net Income | 718MM | +1% |
G&A | 1.8B | -1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Albertsons (ACI) Q4 results reflect its commitment toward operational excellence, digital expansion, pharmacy operations and customer relationships.
Colgate's (CL) first-quarter 2024 performance is likely to gain from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Colgate's (CL) aggressive pricing actions, along with solid business momentum, supported by robust consumer demand and innovation, should craft its successful earnings story.
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Colgate-Palmolive (CL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
With over 50 years of dedication to the mission of making products that are good for the consumer and the planet, Tom's of Maine announces the new Smell Good, Good campaign, challenging consumers to get real about natural under-arm protection by replacing current products with an all-new lineup of Tom's of Maine Deodorant and Antiperspirant.
Key Insights Colgate-Palmolive's estimated fair value is US$124 based on 2 Stage Free Cash Flow to Equity Current share...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums' (IPAR) product launches, brand extension, expansion through new licenses or acquisitions and solid product demand have been aiding growth.